rs13333716

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002661.5(PLCG2):​c.1188C>G​(p.Thr396Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0696 in 1,613,924 control chromosomes in the GnomAD database, including 4,395 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.065 ( 375 hom., cov: 31)
Exomes 𝑓: 0.070 ( 4020 hom. )

Consequence

PLCG2
NM_002661.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.194

Publications

6 publications found
Variant links:
Genes affected
PLCG2 (HGNC:9066): (phospholipase C gamma 2) The protein encoded by this gene is a transmembrane signaling enzyme that catalyzes the conversion of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate to 1D-myo-inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) using calcium as a cofactor. IP3 and DAG are second messenger molecules important for transmitting signals from growth factor receptors and immune system receptors across the cell membrane. Mutations in this gene have been found in autoinflammation, antibody deficiency, and immune dysregulation syndrome and familial cold autoinflammatory syndrome 3. [provided by RefSeq, Mar 2014]
PLCG2 Gene-Disease associations (from GenCC):
  • autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
  • familial cold autoinflammatory syndrome 3
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 16-81895922-C-G is Benign according to our data. Variant chr16-81895922-C-G is described in ClinVar as [Benign]. Clinvar id is 403321.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.194 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0789 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLCG2NM_002661.5 linkc.1188C>G p.Thr396Thr synonymous_variant Exon 13 of 33 ENST00000564138.6 NP_002652.2 P16885
PLCG2NM_001425749.1 linkc.1188C>G p.Thr396Thr synonymous_variant Exon 14 of 34 NP_001412678.1
PLCG2NM_001425750.1 linkc.1188C>G p.Thr396Thr synonymous_variant Exon 13 of 33 NP_001412679.1
PLCG2NM_001425751.1 linkc.1188C>G p.Thr396Thr synonymous_variant Exon 14 of 34 NP_001412680.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLCG2ENST00000564138.6 linkc.1188C>G p.Thr396Thr synonymous_variant Exon 13 of 33 1 NM_002661.5 ENSP00000482457.1 P16885

Frequencies

GnomAD3 genomes
AF:
0.0651
AC:
9901
AN:
152010
Hom.:
372
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0809
Gnomad AMI
AF:
0.0855
Gnomad AMR
AF:
0.0443
Gnomad ASJ
AF:
0.0392
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0254
Gnomad FIN
AF:
0.0479
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0724
Gnomad OTH
AF:
0.0484
GnomAD2 exomes
AF:
0.0525
AC:
13089
AN:
249510
AF XY:
0.0518
show subpopulations
Gnomad AFR exome
AF:
0.0789
Gnomad AMR exome
AF:
0.0358
Gnomad ASJ exome
AF:
0.0394
Gnomad EAS exome
AF:
0.000222
Gnomad FIN exome
AF:
0.0517
Gnomad NFE exome
AF:
0.0701
Gnomad OTH exome
AF:
0.0540
GnomAD4 exome
AF:
0.0700
AC:
102330
AN:
1461796
Hom.:
4020
Cov.:
33
AF XY:
0.0684
AC XY:
49743
AN XY:
727202
show subpopulations
African (AFR)
AF:
0.0824
AC:
2758
AN:
33478
American (AMR)
AF:
0.0364
AC:
1628
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0389
AC:
1017
AN:
26136
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.0274
AC:
2364
AN:
86254
European-Finnish (FIN)
AF:
0.0514
AC:
2746
AN:
53406
Middle Eastern (MID)
AF:
0.0378
AC:
218
AN:
5768
European-Non Finnish (NFE)
AF:
0.0788
AC:
87601
AN:
1111938
Other (OTH)
AF:
0.0661
AC:
3993
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
4806
9613
14419
19226
24032
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3272
6544
9816
13088
16360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0652
AC:
9920
AN:
152128
Hom.:
375
Cov.:
31
AF XY:
0.0629
AC XY:
4674
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.0812
AC:
3367
AN:
41470
American (AMR)
AF:
0.0442
AC:
675
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0392
AC:
136
AN:
3472
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5164
South Asian (SAS)
AF:
0.0256
AC:
123
AN:
4808
European-Finnish (FIN)
AF:
0.0479
AC:
508
AN:
10600
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0724
AC:
4923
AN:
68012
Other (OTH)
AF:
0.0479
AC:
101
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
465
930
1395
1860
2325
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0673
Hom.:
134
Bravo
AF:
0.0661
Asia WGS
AF:
0.0200
AC:
72
AN:
3478
EpiCase
AF:
0.0715
EpiControl
AF:
0.0722

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial cold autoinflammatory syndrome 3 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
5.5
DANN
Benign
0.54
PhyloP100
-0.19
Mutation Taster
=73/27
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13333716; hg19: chr16-81929527; API